Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

This decision follows India's recent landmark ruling disallowing patents for incremental innovations. GSK had already slashed prices of the anti-cancer drug by around a third in India as part of a ...

Revenue from operations inched up 18 percent up to Rs 930 crore from Rs 787 crore last fiscal, the company said in a regulatory filing. Venkatesh has more than 24 years of diverse experience in ...

All thanks to the HUL and GlaxoSmithKline Consumer Healthcare (GSK) merger, which will make it India's biggest food company. The secret of the strength in the HUL-GSK deal is Horlicks, a health ...